Emmis Acquisition Corp. Class A (EMIS)
NASDAQ: EMISHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EMIS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $163.36M
- Dividend yield
- None
- 52-week range
- 9.92 – 10.38
- Day range
- 10.36 – 10.36
- Volume / Avg
- 2.84K / 16.19K
- Beta
- —
- Shares outstanding
- 11.94M
52-week range
EMIS stock today
Shares of Emmis Acquisition (EMIS) finished higher on Nov 20 at $10.36, a gain of 0.15% or $0.015 per share, versus the S&P 500's 3.70% decline. Trading was light, with 2.84K shares changing hands, about 18% of the average daily volume. The stock is trading at or near its 52-week high of $10.38, set on Nov 9, 2026, 4.4% above the 52-week low of $9.92.
EMIS is up 4.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 4.4%.
Summary generated from market data by MetaCap's automated system. Methodology
About Emmis Acquisition
Company profileEmmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on target companies primarily in the service, manufacturing, and distribution sectors, including industrial, business, educational, financial, healthcare, and software services in Southeast Asia and North America.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Peter Joseph Goldstein M.B.A.
- Headquarters
- Fort Lauderdale, FL
- IPO year
- 2025
- Website
- emmisacquisition.com
Emmis Acquisition peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ABEOAbeona Therapeutics Inc. | 2.42 | -1.22% | $165.31M | vs EMIS |
| KRROKorro Bio Inc. | 12.18 | -0.08% | $167.18M | vs EMIS |
| TRDAEntrada Therapeutics Inc. | 4.35 | -6.25% | $170.30M | vs EMIS |
| ORMPOramed Pharmaceuticals Inc. | 3.57 | -3.25% | $155.24M | vs EMIS |
| SIGASIGA Technologies Inc. | 2.40 | -9.43% | $172.45M | vs EMIS |
| IFRXInflaRx N.V. | 1.04 | -4.59% | $153.26M | vs EMIS |
| VOGXVogenx Inc | 11.87 | -7.30% | $176.33M | vs EMIS |
| ELDNEledon Pharmaceuticals Inc. | 1.78 | -6.32% | $150.34M | vs EMIS |
Indexes, lists and sector
Emmis Acquisition stock FAQ
What is Emmis Acquisition's stock price today?
EMIS last traded at $10.36 as of Nov 20, 4:00 PM EST, up 0.15% on the day. Prices are delayed at least 15 minutes.
Who is Emmis Acquisition's CEO?
Mr. Peter Joseph Goldstein M.B.A. is the chief executive officer of Emmis Acquisition Corp. Class A.
What is the EMIS 52-week high?
The 52-week high for EMIS is $10.38 and the 52-week low is $9.92. The stock is currently 0.2% below its high.